Comparison between the two-step and the three-step algorithms for the detection of toxigenic Clostridium difficile.

PURPOSE To evaluate usefulness of applying either the two-step algorithm (Ag-EIAs and CCNA) or the three-step algorithm (all three assays) for better confirmation of toxigenic Clostridium difficile. The antigen enzyme immunoassays (Ag-EIAs) can accurately identify the glutamate dehydrogenase antigen of toxigenic and nontoxigenic Clostridium difficile. Therefore, it is used in combination with a toxin-detecting assay [cell line culture neutralization assay (CCNA), or the enzyme immunoassays for toxins A and B (TOX-A/BII EIA)] to provide specific evidence of Clostridium difficile-associated diarrhoea. MATERIALS AND METHODS A total of 151 nonformed stool specimens were tested by Ag-EIAs, TOX-A/BII EIA, and CCNA. All tests were performed according to the manufacturer's instructions and the results of Ag-EIAs and TOX-A/BII EIA were read using a spectrophotometer at a wavelength of 450 nm. RESULTS A total of 61 (40.7%), 38 (25.3%), and 52 (34.7%) specimens tested positive with Ag-EIA, TOX-A/BII EIA, and CCNA, respectively. Overall, the sensitivity, specificity, negative predictive value, and positive predictive value for Ag-EIA were 94%, 87%, 96.6%, and 80.3%, respectively. Whereas for TOX-A/BII EIA, the sensitivity, specificity, negative predictive value, and positive predictive value were 73.1%, 100%, 87.5%, and 100%, respectively. With the two-step algorithm, all 61 Ag-EIAs-positive cases required 2 days for confirmation. With the three-step algorithm, 37 (60.7%) cases were reported immediately, and the remaining 24 (39.3%) required further testing by CCNA. By applying the two-step algorithm, the workload and cost could be reduced by 28.2% compared with the three-step algorithm. CONCLUSIONS The two-step algorithm is the most practical for accurately detecting toxigenic Clostridium difficile, but it is time-consuming.

[1]  B. Oppenheim,et al.  Evaluation of Diagnostic Tests for Clostridium difficile Infection , 2009, Journal of Clinical Microbiology.

[2]  Mark A. Miller,et al.  Clinical and Epidemiological Aspects of Clostridium difficile , 2008 .

[3]  K. Carroll,et al.  Effective Detection of Toxigenic Clostridium difficile by a Two-Step Algorithm Including Tests for Antigen and Cytotoxin , 2006, Journal of Clinical Microbiology.

[4]  Michael A. John,et al.  Performance of the TechLab C. DIFF CHEK-60 Enzyme Immunoassay (EIA) in Combination with the C. difficile Tox A/B II EIA Kit, the Triage C. difficile Panel Immunoassay, and a Cytotoxin Assay for Diagnosis of Clostridium difficile-Associated Diarrhea , 2004, Journal of Clinical Microbiology.

[5]  S. Poutanen,et al.  Clostridium difficile-associated diarrhea in adults , 2004, Canadian Medical Association Journal.

[6]  J. Lamont,et al.  Clostridium difficile colitis , 2004, European Surgery.

[7]  C. Surawicz,et al.  Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease , 2003, American Journal of Gastroenterology.

[8]  A. Limaye,et al.  Six Rapid Tests for Direct Detection of Clostridium difficile and Its Toxins in Fecal Samples Compared with the Fibroblast Cytotoxicity Assay , 2003, Journal of Clinical Microbiology.

[9]  T. Wilkins,et al.  Clostridium difficile Testing: after 20 Years, Still Challenging , 2003, Journal of Clinical Microbiology.

[10]  Michael A. John,et al.  Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea. , 2003, American journal of clinical pathology.

[11]  M. Wilcox,et al.  Clostridium difficile , 2002, Current opinion in infectious diseases.

[12]  M. Delmée Laboratory diagnosis of Clostridium difficile disease. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  M. Landry,et al.  Evaluation of Biosite Triage Clostridium difficile Panel for Rapid Detection of Clostridium difficile in Stool Samples , 2001, Journal of Clinical Microbiology.

[14]  M. Vaneechoutte,et al.  Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  D. Lyerly,et al.  Genetic Characterization of Toxin A-Negative, Toxin B-Positive Clostridium difficile Isolates by PCR , 2000, Journal of Clinical Microbiology.

[16]  J. Brazier The diagnosis of Clostridium difficile-associated disease. , 1998, The Journal of antimicrobial chemotherapy.

[17]  C. Kelly,et al.  Clostridium difficile infection. , 2015, The New England journal of medicine.

[18]  丸田 浩,et al.  泌尿器科領域におけるantibiotics-associated diarrheaの臨床的検討 : clostridium difficileについて(第284回北海道地方会,学会抄録) , 1987 .

[19]  J. Bartlett Antibiotic associated diarrhea. , 2002, Delaware medical journal.

[20]  J. Bartlett,et al.  Cytotoxicity assay in antibiotic-associated colitis. , 1979, The Journal of infectious diseases.